The current stock price of IINN is 0.7132 USD. In the past month the price decreased by -24.13%. In the past year, price decreased by -16.97%.
ChartMill assigns a fundamental rating of 3 / 10 to IINN. While IINN seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months IINN reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS increased by 36.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -248.27% | ||
| ROE | -864.87% | ||
| Debt/Equity | 0 |
7 analysts have analysed IINN and the average price target is 5.1 USD. This implies a price increase of 615.09% is expected in the next year compared to the current price of 0.7132.
For the next year, analysts expect an EPS growth of 37.14% and a revenue growth -84.67% for IINN
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.3 | 192.719B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.76 | 173.049B | ||
| SYK | STRYKER CORP | 23.7 | 137.017B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 113.066B | ||
| BDX | BECTON DICKINSON AND CO | 14.13 | 59.944B | ||
| IDXX | IDEXX LABORATORIES INC | 43.51 | 51.472B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.47 | 45.675B | ||
| RMD | RESMED INC | 22.12 | 39.65B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.06 | 36.738B | ||
| DXCM | DEXCOM INC | 27.71 | 27.29B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Inspira Technologies Oxy B.H.N.Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The firm is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The company provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
INSPIRA TECHNOLOGIES OXY BHN
Ha-Tidhar St 2
Ra'anana IL
CEO: Dagi Ben-Noon
Employees: 40
Phone: 97299664488
Inspira Technologies Oxy B.H.N.Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The firm is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The company provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
The current stock price of IINN is 0.7132 USD. The price increased by 9.72% in the last trading session.
IINN does not pay a dividend.
IINN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
INSPIRA TECHNOLOGIES OXY BHN (IINN) will report earnings on 2026-03-11.
The outstanding short interest for INSPIRA TECHNOLOGIES OXY BHN (IINN) is 1.08% of its float.